Multiple Myeloma Patient Characteristics and Stem Cell Mobilization Outcomes

505 patients with transplant-eligible multiple myeloma underwent hematopoietic progenitor cell collection between January 2017 and December 2020. This retrospective dataset, authored by Anwar Rjoop, includes demographic, molecular, clinical, treatment, and mobilization regimen data analyzed for factors influencing CD34+ cell yield. Results indicate PR and MF molecular subtypes, deletion 13, and high-risk genetic classification were associated with reduced cell collection.

Use Cases

• Predict CD34+ hematopoietic progenitor cell yield based on molecular subtypes and cytogenetics.
• Analyze the impact of different treatment regimens on stem cell mobilization success.
• Identify patient subgroups with high-risk genetic features for poor mobilization outcomes.

Strengths

• Includes data from 505 patients, providing a substantial cohort for analysis.
• Contains multiple data types: demographic, molecular (FISH, cytogenetics, GEP), clinical, treatment, and mobilization regimen.
• Covers a defined time period from January 2017 to December 2020.

Limitations

• Column-level documentation is absent; field semantics must be inferred after download.
• Row count is unknown, which may limit suitability assessment.
• Data may reflect temporal and institutional bias inherent to a single retrospective study.

Provenance

Source

figshare

Collection Method

Retrospective study of patient records.

Time Range

January 2017 to December 2020

Freshness

Last updated 2026-05-12 17:42:38; freshness should be verified.